Topical Antimicrobial Effectiveness Testing
Test for Preinjection Skin Preparation
1 other identifier
interventional
25
1 country
1
Brief Summary
The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started May 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 2, 2011
CompletedFirst Posted
Study publicly available on registry
June 6, 2011
CompletedResults Posted
Study results publicly available
August 31, 2012
CompletedDecember 11, 2025
November 1, 2025
1 month
June 2, 2011
February 16, 2012
November 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Antimicrobial Efficacy
Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 30 seconds after a single application of test material relative to the baseline bacterial count.
30 seconds after treatment
Antimicrobial Efficacy
Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 10 minutes after a single application of test material relative to the baseline bacterial count.
10 minutes after treatment
Interventions
1.5 ml applicator patient preoperative skin preparation
Eligibility Criteria
You may qualify if:
- in good general health
- have skin within 6 inches of the test sites that is free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders.
You may not qualify if:
- \- topical or systemic antimicrobial exposure within 14 days prior to the Screen Visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- C. R. Bardlead
Study Sites (1)
Microbiotest
Sterling, Virginia, 20164, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jennifer Raeder-Devens
- Organization
- CareFusion
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad H Bashir, MD
Microbiotest
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2011
First Posted
June 6, 2011
Study Start
May 1, 2011
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
December 11, 2025
Results First Posted
August 31, 2012
Record last verified: 2025-11